期刊文献+

膀胱癌患者凝血功能检测的临床意义 被引量:3

下载PDF
导出
摘要 近年来恶性肿瘤患病率逐年增多,恶性肿瘤与凝血异常的研究也逐渐增多,研究发现恶性肿瘤患者常存在凝血功能紊乱,血液可有不同程度的高凝状态,除此之外,凝血功能紊乱也与肿瘤患者深静脉血栓的形成及肿瘤远处转移关系密切。90%以上恶性肿瘤患者存在实验室相关检查指标异常,表现为凝血因子水平升高、血小板计数增高、凝血纤溶系统激活、特异性标志物水平升高等,且升高程度与患者预后密切相关。本文对90例膀胱癌患者的凝血功能指标检测结果作一分析。报告如下。
作者 张延 张翼鹏
机构地区 北京解放军第
出处 《浙江临床医学》 2014年第4期619-620,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献5

二级参考文献83

  • 1李家增.止血异常与恶性肿瘤[J].血栓与止血学,2006,12(2):88-89. 被引量:29
  • 2魏文宁,郭涛,祝建芳,宋善俊.恶性肿瘤血栓前体蛋白水平改变的临床意义[J].中华内科杂志,2006,45(12):1026-1026. 被引量:12
  • 3[1]Kubota T,Andoh K,Sedakata H,et al.Tissue factor released from leukemic cells[J].Thromb Haemostas,1991,65(1):59-63. 被引量:1
  • 4[2]Gordon SG,Benson B.Analysis of serum cancer procoagulant activity and its possible use as a tumor marker[J].Thromb Res,1989,56(3):431-440. 被引量:1
  • 5[3]Noguchi M,Sakai T,Kisiel W.Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells[J].Biochem Biophys Res Commun,1989,160(1):222-227. 被引量:1
  • 6[4]Naschitz JE,Yeshurun D,Lev LM.Thromboembolism in cancer: changing trends[J].Cancer,1993,71(4):1384-1390. 被引量:1
  • 7[5]Levine MN.Prevention of thrombotic disorders in cancer patients undergoing chemotherapy[J].Thromb Haemostas,1997,78(1):133-136. 被引量:1
  • 8[6]AL-Mondhiry H.Betathromboglobulin and platelet factor 4 in patients with cancer: correlation with the stage of disease and the effect of chemotherapy[J].Am J Heamatol,1983,14(2):105-165. 被引量:1
  • 9[7]Wehmeier A,Tschope D,Esser J,et al.Circulationg activated platelets in myeloproliferative disorders[J].Thromb Res,1991,61(3):271-278. 被引量:1
  • 10[8]Grignani G,Paccdhiarini L,Pagliarino M.The possible role of bloos platelets in tumour growth and dissemination[J].Haematologica,1986,71(3):245-55. 被引量:1

共引文献141

同被引文献31

  • 1Dell DD. Deep vein thrombosis in the patient with cancer [J]. Clin J Oncol Nurs,2002,6(1 ):43-46. 被引量:1
  • 2Sutherland DE,Weitz IC ,Liebman HA. Thromboembolic com-plicationsof cancer: epidemiology, pathogenesis, diag- nosis, andtreatment [J]. Am J Hematol, 2003,72 ( 1 ) : 43 - 52. 被引量:1
  • 3Luxembourg B,Bauersachs R. Malignancy and thrombosis: adouble-sided clinical relationship [J]. Vasa,2005,34(4) : 225-234. 被引量:1
  • 4Shen VS, Pollock EW. Fatal pulmonary embolism in can- cerpa-tients:is heparinprophylaxis justified? [J]. South Med J, 1980,73(7) :841-843. 被引量:1
  • 5Levine MN,Lee AY,Kakkar AK. From Trousseau to tar- geted therapy:new insights and innovations in thrombosis and cancer [J]. J Thromb, 2005,73 (7) : 941-943. 被引量:1
  • 6Lugassy G,Fanlanga A,Kskksr A,et al. Thrombosis and cancer [M]. London :Taylor & Francis,2004:117-127. 被引量:1
  • 7Avritscher EB,Cantor SB,Shih YC,et al. Cost-amini- mization analysis of low-amolecnlar-aweight heparin (dalteparin)compared to nnfractionated heparin for inpa- tient treatment of cancer patients with deep venous thrombosis [J]. Support Care Cancer,2004,12(7):531. 被引量:1
  • 8Mousa SA. Low-a molecular-a weight heparin in throm- bosis and cancer [J]. Semin Thromb Hemost, 2004,30 (Suppl 1):25. 被引量:1
  • 9黄妩姣,郑智明,林素香,徐宁,黄宪章,庄俊华.CEA和CA724联合检测在结直肠癌诊断中的应用[J].实用医学杂志,2011,27(12):2252-2254. 被引量:28
  • 10任林,齐晓伟,李世超,唐鹏,姜军.乳腺癌患者凝血指标与临床病理特征的关系[J].第三军医大学学报,2012,34(21):2184-2187. 被引量:11

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部